Co-Authors
This is a "connection" page, showing publications co-authored by Alexander Vlaar and Lieuwe Bos.
Connection Strength
1.268
-
Assessment of Lung Reaeration at 2 Levels of Positive End-expiratory Pressure in Patients With Early and Late COVID-19-related Acute Respiratory Distress Syndrome. J Thorac Imaging. 2021 Sep 01; 36(5):286-293.
Score: 0.241
-
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
Score: 0.226
-
Subphenotyping Acute Respiratory Distress Syndrome in Patients with COVID-19: Consequences for Ventilator Management. Ann Am Thorac Soc. 2020 09; 17(9):1161-1163.
Score: 0.225
-
Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia. Thromb Res. 2020 12; 196:135-137.
Score: 0.225
-
Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers. J Breath Res. 2017 04 11; 11(2):026003.
Score: 0.178
-
Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine. 2021 May; 67:103378.
Score: 0.059
-
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study. Lancet Respir Med. 2021 02; 9(2):139-148.
Score: 0.057
-
PRactice of VENTilation in Patients with Novel Coronavirus Disease (PRoVENT-COVID): rationale and protocol for a national multicenter observational study in The Netherlands. Ann Transl Med. 2020 Oct; 8(19):1251.
Score: 0.057